Induction of the differentiation of hl-60 promyelocytic leukemia cells by curcumin in combination with low levels of vitamin d3

Oncology Research

Volumn 9, Issue 1, 1997, Pages 31-39

  Sokoloski, John A ^a   Shyam, Krishnamurthy ^a   Sartorelli, Alan C ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

Curcumin; Differentiation; Hl 60 leukemia cells; Nf xb; Vitamin d3

Indexed keywords

CAFFEIC ACID; CAFFEIC ACID DERIVATIVE; CALCITRIOL; CD11B ANTIGEN; CHLOROGENIC ACID; COUMARIC ACID; CURCUMIN; DNA BINDING PROTEIN; FERULIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL STRAIN HL 60; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; METABOLISM; MYELOID LEUKEMIA; OXIDATION REDUCTION REACTION; PATHOLOGY;

CAFFEIC ACIDS; CALCITRIOL; CELL DIFFERENTIATION; CELL DIVISION; CHLOROGENIC ACID; COUMARIC ACIDS; CURCUMIN; DNA-BINDING PROTEINS; DRUG SYNERGISM; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID; MACROPHAGE-1 ANTIGEN; NF-KAPPA B; OXIDATION-REDUCTION;

EID: 0030623851     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Srimal, R. C. Curcumin. Drugs Future 12:331-333; 1987.
2. Huang, M.-T.; Lou, Y.-R.; Ma, W.; Newmark, H. L.; Reuhl, K. R.; Conney, A. H. Inhibitory effects of dietary curcumin on forestomach, duodenal and colon carcinogenesis in mice. Cancer Res. 54:5841-5847; 1994.
3. Rao, C.; Rivenson, R. A.; Simi, B.; Reddy, B. S. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 55: 259-266; 1995.
4. Huang, M.-T.; Smart, R. C.; Wong, C.-Q.; Conney, A. H. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-Otetradecanoyl (-) phorboI-13-acetate. Cancer Res. 48:59415946,1988.
5. Kakar, S. S.; Roy, D. Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Cancer Lett. 87:85-89; 1994.
6. Huang, T.-S.; Lee, S.-C.; Lin, J.-K. Suppression of c-jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc. Natl. Acad. Sei. USA 88:5292-5296; 1991.
7. Bina, J.; Lokesh, B. R. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim. Biophys. Acta 1224:255-263; 1994.
8. Brouet, 1.; Oshima, H. Curcumin, an anti-tumor promoter and anti-inflammatory agent, inhibits activation of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun. 206:533-540; 1995.
9. Subramanian, M.; Sreejayan; Rao, M. N. A.; Devasagayam, T. P. A.; Singh, B. B. Diminution of singlet oxygen-induced DNA damage by curcumin and related antioxidants. Mutât. Res. 311:249-255; 1994.
10. Sharma, O. P. Anti-oxidant activity of curcumin and related substances. Biochem. Pharmacol. 25:1811-1812; 1976.
11. Sreejayan; Rao, M. N. A. Curcuminoids as potent inhibitors of lipid peroxidation. J. Pharm. Pharmacol. 46:1013-1016; 1994.
12. Rajakumar, D. V.; Rao, M. N. A. Antioxidant properties of dehydrozingerone and curcumin in rat brain homogenates. Mol. Cell. Biochem. 140:73-79; 1994.
13. Huang, M.-T.; Lysz, T.; Ferraro, T.; Abidi, T. F.; Laskin, J. D.; Conney, A. H. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51:813-819; 1991.
14. Chan, M. M.-Y. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem. Pharmacol. 49:1551-1556; 1995.
15. Singh, S.; Agganval, B. B. Activation of the transcription factor NF-xB is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 270:24995-25000; 1995.
16. Nabel, G.; Baltimore, D. An inducible transcriptional factor activates expression of the human immunodeficiency virus in T cells. Nature 335:683-689; 1987.
17. Baeuerle, P. A.; Baltimore, D. The physiology of the NFkappa-B transcription factor. Mol. Aspects Cell. Regul. 6: 409-432; 1991.
18. Grilli, M.; Chiu, J. J.-S.; Lenardo, M. J. NF-nB and rel: Participants'in a multiform regulatory system. Int. Rev. Cytol. 148:1-63; 1993.
19. Lenardo, M. J.; Baltimore, D. NF-xB: A pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227-229; 1989.
20. Manning, A. M.; Anderson, D. C., Transcription factor NF-κB: An emerging regulator of inflammation. Annu. Rep. Med. Chem. 29:235-244; 1994.
21. Baeuerle, P.A.; Henkel, T. Function and activation of NF-xB in the immune system. Annu. Rev. Immunol. 12:141-179; 1994.
22. Block, G.; Patterson, B.; Subar, A. Fruit, vegetables and cancer prevention: A review of the epidemiological evidence. Nutr. Cancer 18:1-29; 1992.
23. Dragsted, L. O.; Strube, M.; Larsen, J. C. Cancer protective factors in fruits and vegetables: Biochemical and biological background. Pharmacol. Toxicol. 72(SuppI.):S116; 1993.
24. Kumar, S.; Rabson, A. B.; Gelinas, C. The RxxRxRxxC motif conserved in all Rel/kB proteins is essential for the DNAbinding activity and redox regulation of the v-ReI oncoprotein. Mol. Cell. Biol. 12:3094-3106; 1992.
25. Schenk, H.; Klein, M.; Erdbrugger, W.; Droge, W.; SchulzeOsthoff, K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-xB and AP-1. Proc. Natl. Acad. Sei. USA 91:1672-1676; 1994.
26. Schreck, R.; Rieber, P.; Baeuerle, P. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-xB transcription factor and H1V-1. EMBO J. 10:2247-2258; 1991.
27. Toledano, M. B.; Leonard, W. J. Modulation of the transcription factor NF-icB binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sei. USA 88:4328-4332; 1991.
28. Schreck, R.; Meier, B.; Mannel, D. N.; Droge, W.; Baeuerle, P. A. Dithiocarbamates äs potent inhibitors of nuclear factor kB activation in intact cells. J. Exp. Med. 175:1181-1194; 1992.
29. Staal, F. J. T.; Roederer, M.; Herzenberg, L. A.; Herzenberg, L. A. Intracellular thiols regulate activation of nuclear factor kB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sei. USA 87:9943-9947; 1990.
30. Mihm, S.; Ennen, J.; Pessara, U.; Kurth, R.; Droge, W. Inhibition of HIV-1 replication and NF-xB activity by cysteine and cysteine derivatives. AIDS 5:497-502; 1991.
31. Meyer, M.; Schrenck, R.; Baeuerle, P. A. H2O2 and antioxidants have opposite effects on activation of NF-/tB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12:2005-2015; 1993.
32. Thanos, D.; Maniatis, T. NF-xB: A lesson in family values. Cell 80:529-532; 1995.
33. Reiss, M.; Gamba-Vitalo, C.; Sartorelli, A. C. Induction of tumor cell differentiation as a therapeutic approach: Preclinical models for hematopoietic and solid neoplasms. Cancer Treat. Rep. 70:201-217; 1986.
34. Sokoloski, J. A.; Narayanan, R.; Sartorelli, A. C. Role of NF-xB in the differentiation and CDllb expression of HL-60 promyelocytic leukemia cells. Proc. Am. Assoc. Cancer Res. 35:565; 1994.
35. Reitsma, P. H.; Rothberg, P. G.; Astrin, S. M.; Trial, J.; Bar-Shavit, Z.; Hall, A.; Teitelbaum, S. L.; Kahn, A. J. Regulation of myc gene expression in HL-60 leukemia cells by a vitamin D metabolite. Nature 306:492-494; 1983.
36. Mangelsdorf, O. J.; Koeffler, H. P.; Donaldson, C. A.; Pike, J. W.; Hausler, M. R. l,25-Dihydroxyvitamin D, induced differentiation in a human promyelocytic leukemia cell line (HL60): Receptor mediates maturation to macrophage-like cells. J. Cell Biol. 98:391-398; 1984.
37. Pike, J. W. Intracellular receptors mediate the biological action of 1,25-dihydroxyvitamin D3. Nutr. Rev. 43:161-168; 1985.
38. Henry, H. L.; Norman, A. W. Vitamin D: Metabolism and biological actions. Annu. Rev. Nutr. 4:493-520; 1984.
39. 3 on maturation of myeloid leukemic and preleukemic cells. Cancer Treat. Rep. 69:1399-1406; 1985.
40. Dignam, J. D.; Lebovitz, R. M.; Roeder, R. G. Accurate transcriptional initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489; 1983.
41. Zhou, J.-Y.; Norman, A. W.; Lubbert, M.; Collins, M. R.; Uskokovic, M. R.; Koeffler, H. P. Novel vitamin D3 analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone calcium mobilization. Blood 74:82-93; 1989.
42. Dore, B. T.; Uskokovic, M. R.; Koeffler, H. P. Interaction of retinoic acid and vitamin D3 analogs on HL-60 myeloid leukemia cells. Leukemia Res. 17:749-757; 1993.
43. Pakkala, S.; de Vos, S.; Elstner, E.; Rude, R. K.; Uskokovic, M.; Binderups, L.; Koeffler, H. P. Vitamin D3 analogs: Effect on leukemic clonal growth and differentiation, and on serum calcium levels. Leukemia Res. 19:65-72; 1995.
44. Liu, Y.; Chang, R. L.; Cui, X. X.; Newmark, H. L.; Conney, A. H. Synergistic effects of curcumin on aU-trans retinoic acid or la,25-dihydroxyvitamin Dj-induced differentiation in human promyelocytic leukemia HL-60 cells. Oncol. Res. 9(1)19-29; 1997.
45. Srivastava, R. Inhibition of neutrophil response by curcumin. Agents Actions 28:298-303; 1989.
46. Conney, A. H.; Lysz, T.; Ferraro, T.; Abidi, T. F.; Manehand, P. S.; Laskin, J. D.; Huang, M.-T. Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv. Enzyme Regul. 31:385-396; 1988.